| MESOBLAST LTD. |
| Australien |
| Gesundheit |
| AU000000MSB8 / A0DNPW |
| LWB (Frankfurt) |
| FRA:LWB, ETR:LWB, LWB:GR |
| - |
| https://www.mesoblast.com.. |
|
Mesoblast Limited is a biotechnology company specializing in the development of allogeneic, or off-the-shelf, cellular medicines intended for the treatment of severe and life-threatening inflammatory ..
>Volltext.. |
| 1632.44 Mio. EUR |
| 1636.88 Mio. EUR |
| 57.83 Mio. EUR |
| -57.69 Mio. EUR |
| -84.45 Mio. EUR |
| -0.07 EUR |
| 116.63 Mio. EUR |
| 112.17 Mio. EUR |
| -63.29 Mio. EUR |
| 1.01 |
| 1011.51% |
| 10.99% |
| - |
| - |
| - |
| - |
| MESOBLAST |
| 06.03.26 |
|